Legal & General Group
CNTA

Legal & General Group’s Centessa Pharmaceuticals CNTA Stock Holding History

Legal & General Group’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.32M Buy
110,207
+4,780
+5% +$122K ﹤0.01% 1574
2025
Q4 		$2.64M Buy
105,427
+3,734
+4% +$94.6K ﹤0.01% 1860
2025
Q3 		$2.46M Buy
101,693
+3,437
+3% +$61.1K ﹤0.01% 1890
2025
Q2 		$1.29M Buy
98,256
+22,205
+29% +$281K ﹤0.01% 2157
2025
Q1 		$1.09M Buy
76,051
+600
+0.8% +$9.82K ﹤0.01% 2159
2024
Q4 		$1.26M Buy
+75,451
New +$1.25M ﹤0.01% 2163

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Legal & General Group's CNTA Position: Q1 2026 in Review

Legal & General Group increased its Centessa Pharmaceuticals (CNTA) stake by 4.5% in Q1 2026, buying an estimated $122K and bringing the position to 110,207 shares worth $4.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1574.

Legal & General Group first reported a position in CNTA in Q4 2024 and has held it in 6 quarters since. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Legal & General Group held 110,207 shares of Centessa Pharmaceuticals worth $4.32M as of Q1 2026.
  • Legal & General Group bought 4,780 Centessa Pharmaceuticals shares in Q1 2026, an estimated $122K.
  • Centessa Pharmaceuticals made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #1574 holding.
  • Legal & General Group first reported a position in Centessa Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.